Takafumi Koyauchi

Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study

Yuzo Suzuki, Masato Karayama, Tomohiro Uto et al. · Journal of Thoracic Oncology · 2020 · 107 citations · Full text

Medicine, Immunology, Oncology +15

Efficacy and Tolerability of High-Flow Nasal Cannula Oxygen Therapy for Hypoxemic Respiratory Failure in Patients with Interstitial Lung Disease with Do-Not-Intubate Orders: A Retrospective Single-Center Study

Takafumi Koyauchi, Hirotsugu Hasegawa, Kei Kanata et al. · Respiration · 2018 · 88 citations · Full text

Health Professions, Internal Medicine, Respiratory Therapy +15

Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer

Yuichi Ozawa, Yusuke Amano, Kei Kanata et al. · Medical Oncology · 2019 · 74 citations

Medicine, Oncology, Pharmacotherapy +16

Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study

Takafumi Koyauchi, Yuzo Suzuki, Kazuki Sato et al. · Thorax · 2020 · 26 citations · Full text

Medicine, Oncology, Bereavement Care +10

Pulse oximetric saturation to fraction of inspired oxygen (SpO₂/FIO₂) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease

Takafumi Koyauchi, Hideki Yasui, Noriyuki Enomoto et al. · Therapeutic Advances in Respiratory Disease · 2020 · 18 citations · Full text

Medicine, Internal Medicine, Pulmonary Function Testing +14